This mutation fuses the nucleophosmin (NPM) gene with the ALK gene and was first explained in Ki-1 Lymphoma
This mutation fuses the nucleophosmin (NPM) gene with the ALK gene and was first explained in Ki-1 Lymphoma. ROS1 (RXDX-101, PF-06463922) are under active clinical development. strong class=”kwd-title” Keywords: Anaplastic lymphoma kinase, ALK-1, Crizotinib, Ceritinib…